FDA Inspection 848887 — Propak Development, Inc.

Propak Development, Inc. — FEI 3004420929

The FDA completed an inspection of Propak Development, Inc. on Sep 23, 2013 in Dayton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 23, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dayton, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.